Clinical Trials Directory

Trials / Completed

CompletedNCT03664310

Transdiagnostic Sleep and Anxiety Treatment

A Pilot Study and Randomized Controlled Trial of Transdiagnostic Sleep and Anxiety Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Florida State University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.

Conditions

Interventions

TypeNameDescription
OTHERFSET Anxiety and Sleep TreatmentComputerized anxiety and insomnia intervention.
OTHERControlPhysical health control

Timeline

Start date
2017-08-01
Primary completion
2018-05-12
Completion
2018-05-12
First posted
2018-09-10
Last updated
2021-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03664310. Inclusion in this directory is not an endorsement.